Table 4. The Predicted Tumor Risk Category Results (Number of Patients).
Mitotic Index | Training Cohort (n = 108) | Validation Cohort (n = 20) | Test Cohort (n = 20) | |||
---|---|---|---|---|---|---|
Low-Mitotic | High-Mitotic | Low-Mitotic | High-Mitotic | Low-Mitotic | High-Mitotic | |
True | 50 | 50 | 7 | 9 | 8 | 10 |
False | 4 | 4 | 3 | 1 | 2 | 0 |
Total | 54 | 54 | 10 | 10 | 10 | 10 |
Accuracy (95% CI), % | 92.6 (0.876–0.976) | 80.0 (0.608–0.992) | 90.0 (0.756–1.000) | |||
Sensitivity (95% CI), % | 92.6 (0.813–0.986) | 90.0 (0.541–0.995) | 100.0 (0.656–1.000) | |||
Specificity (95% CI), % | 92.6 (0.813–0.986) | 70.0 (0.354–0.919) | 80.0 (0.442–0.965) | |||
Positive predictive value (95% CI), % | 92.6 (0.813–0.986) | 75.0 (0.428–0.933) | 83.3 (0.509–0.971) | |||
Negative predictive value (95% CI), % | 92.6 (0.813–0.986) | 87.5 (0.467–0.993) | 100.0 (0.598–1.000) |